Ajanta Pharma Limited has announced the re-appointment of its internal, cost, and tax auditors following a board meeting held on May 5, 2026. These appointments ensure the continuity of financial oversight and compliance for the 2026-27 financial year. The company remains committed to maintaining high standards of audit quality and governance through these seasoned firms.
Continuity in Financial Governance
Following a recent board meeting, Ajanta Pharma has formally approved the re-appointment of its professional auditing partners for the upcoming financial cycle. This decision reinforces the company’s commitment to robust financial reporting and institutional transparency as it enters the 2026-27 fiscal year.
Details of Auditor Appointments
The company has finalized the following appointments to support its audit and taxation functions:
- Internal Auditor: M/s. Aneja Assurance Pvt. Ltd. has been re-appointed to oversee internal audit and risk advisory functions. The firm brings over 40 years of industry experience, covering sectors including pharmaceuticals and manufacturing.
- Cost Auditor: M/s. RA & Co. will continue their engagement as Cost Auditors. This appointment remains subject to the ratification of their remuneration by the company’s shareholders.
- Tax Auditor: M/s. R S Sanghai & Associates has been re-appointed to manage the firm’s direct and indirect tax compliance, ensuring timely and quality deliverables.
Strategic Oversight
These firms have been selected based on their established expertise and deep understanding of the pharmaceutical sector. By retaining these auditors, the company maintains its adherence to global standards and ensures the continued effectiveness of its internal controls and regulatory obligations throughout the 2026-27 period.
Source: BSE
